Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Medpace Holdings, Inc.

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Return on Invested Capital

Return on Invested Capital %Chg

Return on Assets

Return on Assets %Chg

Return on Equity

Return on Equity %Chg

Return on Total Capital

Return on Total Capital %Chg

Return on Capital Employed

Return on Capital Employed %Chg

Return on Tangible Assets

Return on Tangible Assets %Chg

Receivables Turnover

Receivables Turnover %Chg

Days Sales Outstanding

Days Sales Outstanding %Chg

Payables Turnover

Payables Turnover %Chg

Days Payables Outstanding

Days Payables Outstanding %Chg

Cash Conversion Cycle

Cash Conversion Cycle %Chg

Asset Turnover

Asset Turnover %Chg

Fixed Asset Turnover

Fixed Asset Turnover %Chg

Operating Cycle

Operating Cycle %Chg

CapEx to OCF

CapEx to OCF %Chg

CapEx to Revenue

CapEx to Revenue %Chg

CapEx to Depreciation

CapEx to Depreciation %Chg

SG&A to Revenue

SG&A to Revenue %Chg

Stock-based Comp to Revenue

Stock-based Comp to Revenue %Chg

Total Debt

Total Debt %Chg

Net Debt

Net Debt %Chg

Current Ratio

Current Ratio %Chg

Quick Ratio

Quick Ratio %Chg

Cash Ratio

Cash Ratio %Chg

Debt Ratio

Debt Ratio %Chg

Assets to Equity

Assets to Equity %Chg

Cash Flow to Debt Ratio

Cash Flow to Debt Ratio %Chg

Long-term Debt to Assets

Long-term Debt to Assets %Chg

Intangibles to Total Assets

Intangibles to Total Assets %Chg

Net Current Asset Value

Net Current Asset Value %Chg

Goodwill / Assets

Goodwill / Assets %Chg

Debt / Equity

Debt / Equity %Chg

Total Debt / Capitalization

Total Debt / Capitalization %Chg

Long Term Debt / Capitalization

Long Term Debt / Capitalization %Chg

Long-Term Debt / Equity

Long-Term Debt / Equity %Chg

Net Debt / EBITDA

Net Debt / EBITDA %Chg

EBIT / Interest Expense

EBIT / Interest Expense %Chg

EBITDA / Interest Expense

EBITDA / Interest Expense %Chg

(EBITDA - Capex) / Interest Expense

(EBITDA - Capex) / Interest Expense %Chg

Diluted EPS 1Y Growth

Diluted EPS 1Y Growth %Chg

Diluted EPS 3Y CAGR

Diluted EPS 3Y CAGR %Chg

Diluted EPS 5Y CAGR

Diluted EPS 5Y CAGR %Chg

Diluted EPS 10Y CAGR

Levered Free Cash Flow 1Y Growth

Levered Free Cash Flow 1Y Growth %Chg

Levered Free Cash Flow 3Y CAGR

Levered Free Cash Flow 3Y CAGR %Chg

Levered Free Cash Flow 5Y CAGR

Levered Free Cash Flow 5Y CAGR %Chg

Total Equity 1Y Growth

Total Equity 1Y Growth %Chg

Total Equity 3Y CAGR

Total Equity 3Y CAGR %Chg

Total Equity 5Y CAGR

Total Equity 5Y CAGR %Chg

Total Equity 10Y CAGR

Accounts Receivable 1Y Growth

Accounts Receivable 1Y Growth %Chg

Accounts Receivable 3Y CAGR

Accounts Receivable 3Y CAGR %Chg

Accounts Receivable 5Y CAGR

Accounts Receivable 5Y CAGR %Chg

Accounts Receivable 10Y CAGR

Tangible Book Value 1Y Growth

Tangible Book Value 1Y Growth %Chg

Tangible Book Value 3Y CAGR

Tangible Book Value 3Y CAGR %Chg

Tangible Book Value 5Y CAGR

Tangible Book Value 5Y CAGR %Chg

Unlevered Free Cash Flow 1Y Growth

Unlevered Free Cash Flow 1Y Growth %Chg

Unlevered Free Cash Flow 3Y CAGR

Unlevered Free Cash Flow 3Y CAGR %Chg

Unlevered Free Cash Flow 5Y CAGR

Unlevered Free Cash Flow 5Y CAGR %Chg

Revenue 1Y Growth

Revenue 1Y Growth %Chg

Revenue 3Y CAGR

Revenue 3Y CAGR %Chg

Revenue 5Y CAGR

Revenue 5Y CAGR %Chg

Gross Profit 1Y Growth

Gross Profit 1Y Growth %Chg

Gross Profit 3Y CAGR

Gross Profit 3Y CAGR %Chg

Gross Profit 5Y CAGR

Gross Profit 5Y CAGR %Chg

EBITDA 1Y Growth

EBITDA 1Y Growth %Chg

EBITDA 3Y CAGR

EBITDA 3Y CAGR %Chg

EBITDA 5Y CAGR

EBITDA 5Y CAGR %Chg

EBIT 1Y Growth

EBIT 1Y Growth %Chg

EBIT 3Y CAGR

EBIT 3Y CAGR %Chg

EBIT 5Y CAGR

EBIT 5Y CAGR %Chg

EBIT 10Y CAGR

Earnings From Cont. Operations 1Y Growth

Earnings From Cont. Operations 1Y Growth %Chg

Earnings From Cont. Operations 3Y CAGR

Earnings From Cont. Operations 3Y CAGR %Chg

Earnings From Cont. Operations 5Y CAGR

Earnings From Cont. Operations 5Y CAGR %Chg

Net Income 1Y Growth

Net Income 1Y Growth %Chg

Net Income 3Y CAGR

Net Income 3Y CAGR %Chg

Net Income 5Y CAGR

Net Income 5Y CAGR %Chg

Plant and Equip. 1Y Growth

Plant and Equip. 1Y Growth %Chg

Plant and Equip. 3Y CAGR

Plant and Equip. 3Y CAGR %Chg

Plant and Equip. 5Y CAGR

Plant and Equip. 5Y CAGR %Chg

Plant and Equip. 10Y CAGR

Common Equity 1Y Growth

Common Equity 1Y Growth %Chg

Common Equity 3Y CAGR

Common Equity 3Y CAGR %Chg

Common Equity 5Y CAGR

Common Equity 5Y CAGR %Chg

Common Equity 10Y CAGR

Total Assets 1Y Growth

Total Assets 1Y Growth %Chg

Total Assets 3Y CAGR

Total Assets 3Y CAGR %Chg

Total Assets 5Y CAGR

Total Assets 5Y CAGR %Chg

Total Assets 10Y CAGR

Cash From Operations 1Y Growth

Cash From Operations 1Y Growth %Chg

Cash From Operations 3Y CAGR

Gross Profit Margin

Gross Profit Margin %Chg

Operating Margin

Operating Margin %Chg

EBITDA Margin

Trailing Valuation	LTM
Stock Price	551.2
Total Shares Outstanding	28.2
Market Cap	15,527.5
Total Enterprise Value (TEV)	15,361.2
Buyback Yield	6.8%
Shareholder Yield	6.8%
P/S	6.6
P/Gross Profit	21.2
P/E	38.5
Earnings Yield	2.6%
P/OCF	21.8
P/FCF	22.9
FCF Yield	4.4%
P/B	52.9
EV/Sales	6.5
EV/Gross Profit	20.9
EV/EBITDA	28.7
EV/EBIT	30.3
EV/OCF	21.6
EV/FCF	22.7

Margins	LTM
Gross Profit Margin	31.1%
Operating Margin	21.5%
EBITDA Margin	22.7%
Net Profit Margin	18.4%
Effective Tax Rate	16.6%
Pre-Tax Profit Margin	22%
Free Cash Flow Margin	28.7%
OCF / Sales	30.2%
OCF / Net Income	164.3%
FCF / OCF	95.2%
FCF / Net Income	156.3%
FCF / EBITDA	126.4%

Per Share	LTM
Revenue per Share	77.9
Basic EPS	14.7
Diluted EPS	14.3
Book Value per Share	9.7
Tangible Book Value per Share	-13.3
Cash per Share	9.4
Operating Cash Flow per Share	23.5
Free Cash Flow per Share	22.4
CapEx per Share	1.1
Weighted Avg. Shares Outstanding	29.5
Weighted Avg. Shares Outstanding Diluted	30.3

Common Size	LTM
SG&A to Revenue	8.4%
Stock-based Comp to Revenue	1.5%

Capital Efficiency	LTM
Return on Invested Capital	22.2%
Return on Assets	21.9%
Return on Equity	77.4%
Return on Total Capital	354.2%
Return on Capital Employed	108.1%
Return on Tangible Assets	41%
Receivables Turnover	7
Days Sales Outstanding	51.8
Payables Turnover	55
Days Payables Outstanding	6.6
Cash Conversion Cycle	45.2
Asset Turnover	1.2
Fixed Asset Turnover	9.3
Operating Cycle	51.8
CapEx to OCF	0
CapEx to Revenue	0
CapEx to Depreciation	1.2

Financial Health	LTM
Total Debt	119.1
Net Debt	-166.3
Current Ratio	0.6
Quick Ratio	0.5
Cash Ratio	0.2
Debt Ratio	0.1
Assets to Equity	6
Cash Flow to Debt Ratio	6
Long-term Debt to Assets	0.1
Intangibles to Total Assets	0.4
Net Current Asset Value	-722.1
Goodwill / Assets	0.4
Debt / Equity	0.4
Total Debt / Capitalization	1
Long Term Debt / Capitalization	1
Long-Term Debt / Equity	0.4
Net Debt / EBITDA	-0.3